VACCINE RESPONSE IMPAIRED
Clinical trials for VACCINE RESPONSE IMPAIRED explained in plain language.
Never miss a new study
Get alerted when new VACCINE RESPONSE IMPAIRED trials appear
Sign up with your email to follow new studies for VACCINE RESPONSE IMPAIRED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New RSV vaccine trial aims to protect vulnerable transplant recipients
⭐️ VACCINE ⭐️ OngoingThis phase 3 trial is testing a non-live, adjuvanted RSV vaccine (Arexvy) in 100 adults who have received a lung or stem cell transplant. The goal is to see if the vaccine is safe and helps their immune system fight RSV, a common virus that can be dangerous for them. Participants…
Matched conditions: VACCINE RESPONSE IMPAIRED
Phase: PHASE3 • Sponsor: University Health Network, Toronto • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:28 UTC
-
Kidney transplant study tests vaccine booster strategy
Knowledge-focused OngoingThis study looks at whether temporarily reducing immunosuppressive medication can help kidney transplant recipients mount a stronger immune response to a third dose of the COVID-19 mRNA vaccine. Fourteen participants with low or no antibodies will have their antimetabolite dose l…
Matched conditions: VACCINE RESPONSE IMPAIRED
Phase: PHASE4 • Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC